tradingkey.logo
tradingkey.logo
Suchen

908 Devices Inc.

MASS
Zur Watchlist hinzufügen
8.690USD
-0.190-2.14%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
315.64MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über 908 Devices Inc. Unternehmen

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

908 Devices Inc. Informationen

BörsenkürzelMASS
Name des Unternehmens908 Devices Inc
IPO-datumDec 18, 2020
CEOKnopp (Kevin J)
Anzahl der mitarbeiter246
WertpapierartOrdinary Share
GeschäftsjahresendeDec 18
Addresse44 Third Avenue
StadtBURLINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01803
Telefon19787294478
Websitehttps://908devices.com/
BörsenkürzelMASS
IPO-datumDec 18, 2020
CEOKnopp (Kevin J)

Führungskräfte von 908 Devices Inc.

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.27M
-4.96%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
865.56K
-3.47%
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
89.35K
+15.76%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
40.90K
+34.44%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
39.37K
+33.01%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
27.05K
+76.03%
Mr. Tony John Hunt
Mr. Tony John Hunt
Independent Director
Independent Director
--
--
Dr. Kevin Mccallion, Ph.D.
Dr. Kevin Mccallion, Ph.D.
Vice President - Production and New Product Introduction
Vice President - Production and New Product Introduction
--
--
Mr. Don Osmer
Mr. Don Osmer
Vice President - Human Resources
Vice President - Human Resources
--
--
Ms. Barbara Russo
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.27M
-4.96%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
865.56K
-3.47%
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
89.35K
+15.76%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
40.90K
+34.44%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
39.37K
+33.01%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
27.05K
+76.03%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von 908 Devices Inc.?

Die fünf größten Anteilseigner von 908 Devices Inc. sind: Dr. Kevin J. Knopp, Ph.D.

Wie viele Institutionen halten Anteile an 908 Devices Inc. (MASS)?

Mit Stand vom 2026Q1 halten 247 Institutionen Anteile an 908 Devices Inc., mit einem Gesamtmarktwert von etwa 28.68M, was 75.86% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -11065134.00 gestiegen.

Was ist die größte Einnahmequelle von 908 Devices Inc.?

Am 2026Q1 erzielte das Geschäft mit Device sales revenue für 908 Devices Inc. den höchsten Umsatz in Höhe von 36.66M, was 65.23% des Gesamtumsatzes entspricht.